Atropos Health partners with Norstella to expand the Atropos Evidence™ Network and structured clinical trial intelligence

Published on June 17, 2024

BOSTON – June 17, 2024 – Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. This collaboration follows Atropos Health’s recent announcement of $33 million in Series B funding, furthering its expansion into life sciences.

Continue reading on website
Other news

Putting the patient first: Advancing biopharma innovation and industry transformation

June 17, 2024
Norstella is driven by its mission: Helping patients gain access to life-saving therapies by transforming the drug development journey. Norstella is working to fulfill this mission in a challenging landscape for pharmaceutical, medtech, and clinical research organizations. With this as the context, Norstella recently held a recent roundtable discussion in London featuring several members of […]

Webinar: Helping therapeutic developers to build cell therapy candidates

June 18, 2024
"Cellistic offers therapeutic developers a new path towards iPSC allogeneic cell therapy product development"